155 related articles for article (PubMed ID: 26363899)
21. Clinical pharmacokinetics, pharmacodynamics, safety and tolerability of darexaban, an oral direct factor Xa inhibitor, in healthy Caucasian and Japanese subjects.
Kadokura T; Kashiwa M; Groenendaal D; Heeringa M; Mol R; Verheggen F; Garcia-Hernandez A; Onkels H
Biopharm Drug Dispos; 2013 Nov; 34(8):431-41. PubMed ID: 23929659
[TBL] [Abstract][Full Text] [Related]
22. A phase 1 study to assess the pharmacokinetics, safety, and tolerability of fremanezumab doses (225 mg, 675 mg and 900 mg) in Japanese and Caucasian healthy subjects.
Cohen-Barak O; Weiss S; Rasamoelisolo M; Faulhaber N; Yeung PP; Loupe PS; Yoon E; Gandhi MD; Spiegelstein O; Aycardi E
Cephalalgia; 2018 Nov; 38(13):1960-1971. PubMed ID: 29667896
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of QMF149 in Japanese versus Caucasian subjects: an open-label, randomized phase I study.
Shimada S; Vaidya S; Khindri S; Tashiro N; Cheng Y; Hara H; Majumdar T; Woessner R; Furihata K; Kobayashi K
Int J Clin Pharmacol Ther; 2015 May; 53(5):398-407. PubMed ID: 25740265
[TBL] [Abstract][Full Text] [Related]
24. A phase 1, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and pharmacokinetics of single and multiple doses of lisdexamfetamine dimesylate in Japanese and Caucasian healthy adult subjects.
Ermer J; Martin P; Corcoran M; Matsuo Y
Neuropsychopharmacol Rep; 2020 Mar; 40(1):16-29. PubMed ID: 31765110
[TBL] [Abstract][Full Text] [Related]
25. Ethnic Sensitivity Study of the Extrafine, Single-Inhaler, Triple Therapy Beclomethasone Dipropionate, Formoterol Fumarate, and Glycopyrronium Bromide Pressurized Metered Dose Inhaler in Japanese and Caucasian Healthy Individuals: A Randomized, Double-Blind, Single-Dose Crossover Study.
Cella M; Täubel J; Delestre-Levai I; Tulard A; Vele A; Georges G
Clin Ther; 2021 Nov; 43(11):1934-1947.e4. PubMed ID: 34600734
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics, Safety, and Tolerability of Anti-SARS-CoV-2 Monoclonal Antibody, Sotrovimab, Delivered Intravenously or Intramuscularly in Japanese and Caucasian Healthy Volunteers.
Nader A; Alexander E; Brintziki D; Haggag AZ; Harrison SA; Hawes IA; Hezareh M; Lippa AM; Okamasa A; Okour M; Okuda N; Sager JE; Segal S; Shida Y; Skingsley A; Williams R; Yoon EY; Austin D
Clin Pharmacokinet; 2024 Jan; 63(1):57-68. PubMed ID: 37955825
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics and safety of sirukumab following a single subcutaneous administration to healthy Japanese and Caucasian subjects.
Zhuang Y; Xu Z; de Vries DE; Wang Q; Shishido A; Comisar C; Ford JA; Keen M; Achira M; Tsukamoto Y; Petty KJ; Davis HM; Zhou H
Int J Clin Pharmacol Ther; 2013 Mar; 51(3):187-99. PubMed ID: 23357841
[TBL] [Abstract][Full Text] [Related]
28. Lidocaine priming reduces ADP-induced P-selectin expression and platelet-leukocyte aggregation.
Huang GS; Lin TC; Wang JY; Ku CH; Ho ST; Li CY
Acta Anaesthesiol Taiwan; 2009 Jun; 47(2):56-61. PubMed ID: 19527965
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics and Safety of Mavatrep (JNJ-39439335), a TRPV1 Antagonist in Healthy Japanese and Caucasian Men: A Double-Blind, Randomized, Placebo-Controlled, Sequential-Group Phase 1 Study.
Manitpisitkul P; Shalayda K; Russell L; Sanga P; Solanki B; Caruso J; Iwaki Y; Moyer JA
Clin Pharmacol Drug Dev; 2018 Sep; 7(7):712-726. PubMed ID: 29125703
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics, Safety, and Tolerability of a New Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate Diskus(®) in Healthy Adults.
Vutikullird AB; Gillespie M; Song S; Steinfeld J
J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):207-14. PubMed ID: 26624976
[TBL] [Abstract][Full Text] [Related]
31. Randomized, double-blind, placebo-controlled, phase I study of the safety and pharmacokinetics of namilumab in healthy Japanese and Caucasian men
.
Tanaka S; Harada S; Hiramatsu N; Nakaya R; Kawamura M
Int J Clin Pharmacol Ther; 2018 Nov; 56(11):507-517. PubMed ID: 30168415
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics, pharmacodynamics and safety of single, oral doses of GSK1278863, a novel HIF-prolyl hydroxylase inhibitor, in healthy Japanese and Caucasian subjects.
Hara K; Takahashi N; Wakamatsu A; Caltabiano S
Drug Metab Pharmacokinet; 2015 Dec; 30(6):410-8. PubMed ID: 26643993
[TBL] [Abstract][Full Text] [Related]
33. The pharmacokinetics and pharmacodynamics of prasugrel in healthy Chinese, Japanese, and Korean subjects compared with healthy Caucasian subjects.
Small DS; Kothare P; Yuen E; Lachno DR; Li YG; Winters KJ; Farid NA; Ni L; Jakubowski JA; Salazar DE; Thieu VT; Payne CD
Eur J Clin Pharmacol; 2010 Feb; 66(2):127-35. PubMed ID: 19888568
[TBL] [Abstract][Full Text] [Related]
34. Comparable pharmacokinetics and pharmacodynamics of melagatran in Japanese and caucasian volunteers after oral administration of the direct thrombin inhibitor ximelagatran.
Wernevik LC; Nyström P; Andersson M; Johnsson G; Bylock A; Nakanishi T; Eriksson UG
Clin Pharmacokinet; 2006; 45(1):85-94. PubMed ID: 16430313
[TBL] [Abstract][Full Text] [Related]
35. Ataluren Pharmacokinetics in Healthy Japanese and Caucasian Subjects.
Kong R; Laskin OL; Kaushik D; Jin F; Ma J; McIntosh J; Souza M; Almstead N
Clin Pharmacol Drug Dev; 2019 Feb; 8(2):172-178. PubMed ID: 30629861
[TBL] [Abstract][Full Text] [Related]
36. Galantamine pharmacokinetics, safety, and tolerability profiles are similar in healthy Caucasian and Japanese subjects.
Zhao Q; Brett M; Van Osselaer N; Huang F; Raoult A; Van Peer A; Verhaeghe T; Hust R
J Clin Pharmacol; 2002 Sep; 42(9):1002-10. PubMed ID: 12211216
[TBL] [Abstract][Full Text] [Related]
37. Aliskiren, a novel orally effective renin inhibitor, exhibits similar pharmacokinetics and pharmacodynamics in Japanese and Caucasian subjects.
Vaidyanathan S; Jermany J; Yeh C; Bizot MN; Camisasca R
Br J Clin Pharmacol; 2006 Dec; 62(6):690-8. PubMed ID: 17118124
[TBL] [Abstract][Full Text] [Related]
38. Pharmacodynamics and pharmacokinetics of single doses of prasugrel 30 mg and clopidogrel 300 mg in healthy Chinese and white volunteers: an open-label trial.
Small DS; Payne CD; Kothare P; Yuen E; Natanegara F; Teng Loh M; Jakubowski JA; Richard Lachno D; Li YG; Winters KJ; Farid NA; Ni L; Salazar DE; Tomlin M; Kelly R
Clin Ther; 2010 Feb; 32(2):365-79. PubMed ID: 20206794
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics and pharmacodynamics of single-dose oral tolvaptan in fasted and non-fasted states in healthy Caucasian and Japanese male subjects.
Shoaf SE; Kim SR; Bricmont P; Mallikaarjun S
Eur J Clin Pharmacol; 2012 Dec; 68(12):1595-603. PubMed ID: 22585285
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the Pharmacokinetics, Pharmacodynamics, and Safety of a Single Dose of Emicizumab in Healthy Chinese Subjects.
Li H; Zhang W; Petry C; Li L; Fernandez E; Kiialainen A; Feng S; Hsu W; Li L; Wei Y; Schmitt C
Clin Pharmacol Drug Dev; 2021 Jan; 10(1):30-38. PubMed ID: 32433829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
